tiprankstipranks
Aclaris Therapeutics (ACRS)
NASDAQ:ACRS

Compare Aclaris Therapeutics (ACRS) vs. Competitors

891 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Aclaris Therapeutics
$4.08
$487.20M
-4.66
274.07%
3 Buy
0 Hold
0 Sell
Strong Buy
Inotiv
$0.54
$7.88M
-0.17
-83.76%
2 Buy
0 Hold
0 Sell
Moderate Buy
MDxHealth
$2.07
$104.78M
-5.33
38.78%
5 Buy
0 Hold
0 Sell
Strong Buy
Neuronetics
$1.35
$93.52M
-2.33
-64.19%
2 Buy
0 Hold
0 Sell
Moderate Buy
Exagen
$3.09
$72.88M
-6.57
-28.37%
7 Buy
0 Hold
0 Sell
Strong Buy
Sera Prognostics
$2.09
$77.11M
-4.40
-36.66%
2 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ACRS
Aclaris Therapeutics
4.04
2.89
251.30%
NOTV
Inotiv
0.23
-1.27
-84.73%
MDXH
MDxHealth
2.04
0.47
29.94%
STIM
Neuronetics
1.35
-2.44
-64.38%
XGN
Exagen
3.03
-1.23
-28.87%
SERA
Sera Prognostics
1.97
-1.28
-39.38%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts